Form 4: CareDx Executive Sells Shares Under 10b5-1 Plan

CareDx Secretary and General Counsel Jeffrey Adam Novack sold 7,293 shares of common stock on December 4, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Jeffrey Adam Novack, the Secretary and General Counsel of CareDx, Inc. (CDNA), reported the sale of common stock.
• On December 4, 2025, Novack sold 7,007 shares of common stock at a weighted average price of $19.146 per share. The individual sales prices for these shares ranged from $18.69 to $19.67.
• On the same date, an additional 286 shares of common stock were sold at a weighted average price of $19.7495 per share, with individual prices ranging from $19.73 to $19.76.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan, which Novack adopted on September 4, 2025.
• Following these reported transactions, Novack directly beneficially owns 97,925 shares of CareDx common stock.

Sentiment

Score: 5

Explanation: A Form 4 filing is a routine disclosure of insider transactions and does not inherently convey positive or negative sentiment about the company's performance or outlook, especially when conducted under a pre-arranged 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, pre-planned insider sale, not indicative of a change in company fundamentals or management's confidence.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Keywords

CareDx, CDNA, Form 4, insider trading, stock sale, executive, Jeffrey Adam Novack, 10b5-1 plan, beneficial ownership